Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study
about
Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening testsEpigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.Advances in Fecal Occult Blood Tests: the FIT revolution.Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseasesPerformance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control studyEvaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples.Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review.Algorithm Optimization in Methylation Detection with Multiple RT-qPCRA Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis.Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis.Colorectal cancer screening: An updated review of the available options.Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis.Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer.A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis.Plasma methylated septin 9: a colorectal cancer screening marker.The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis.Tumor-associated DNA mutation detection in individuals undergoing colonoscopy.Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice.A pooled analysis of the diagnostic efficacy of plasmic methylated septin-9 as a novel biomarker for colorectal cancer.The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location.Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples.Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection.Fecal immunochemical tests in combination with blood tests for colorectal cancer and advanced adenoma detection-systematic review.Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.Developing DNA methylation-based diagnostic biomarkers.Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm.Progress on the clinical application of the SEPT9 gene methylation assay in the past 5 years.Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.Diagnostic Performance of Intestinal Fusobacterium nucleatum in Colorectal Cancer: A Meta-Analysis.Diagnostic Value of Methylated for Colorectal Cancer DetectionThe Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA
P2860
Q28079672-1E47EAD0-903E-40C1-A5CC-83657D70E27FQ34487177-52852F64-7B91-44FE-932E-15EA240160F8Q34666990-B2A87D29-DDF5-44FF-A9CA-49F52232728AQ34744294-EE9B9E05-16AF-4822-A302-0D7FCFCBA222Q35340073-3E1DC960-7BD8-4845-AF15-43E3AAEF2BB6Q35826444-62FDEA82-6CCA-4085-BF0F-96BE84A185D2Q35863163-0DE199EB-6FA9-4C9D-85E5-0E27B60D11DEQ36012080-619D1329-1757-4047-B887-8CD1F764B331Q36206682-2F1B10E0-2061-45D9-A0F8-49B5A7C9752AQ36534739-BFA3FAAE-CE42-401D-9146-2D13BE42985EQ37296090-2D15A143-32B1-44B4-809F-6DD0D336F40FQ37580040-C45FAF20-B9E9-4CA0-B046-654490E7B402Q37620355-65CDE174-F51D-4312-B2A9-32AD1CAAA3A9Q38368844-4A6EF8CF-CD1E-4E64-9FA1-340A51DAD9B1Q38664513-2FABF36E-3A95-480B-8741-809692A893F7Q38982638-A73F53A2-0DDB-44F1-8D8C-BC1CCA650343Q38995620-3C56D9B7-E162-490D-89DE-C16AD914AAF3Q39093542-1E93C088-40F4-4F2B-9313-7A48552ECC11Q39360779-8E732EA0-AAF5-4B94-ACA0-412E3FE066A8Q46393954-44992ADA-F952-47D8-A555-CB5CDC1C6A4EQ46441513-BCA70E48-7299-45B3-968E-E3AE5B6AFF03Q47094925-BCAB7C23-8DED-4534-901E-44DAE117BC73Q47851396-58771379-131C-48B7-A25D-081FC8A5DD0BQ48017354-01BBBA71-5B92-4C14-BB0E-36566F45224AQ49199264-8724B540-C9F4-401B-A5C3-2DC905B43AEEQ50052522-C8BD8629-6C23-486B-B788-BBF9B1452C6BQ50981768-B86A56C6-B877-4814-9397-B85923637E0CQ52370391-0EE65BF0-9B4D-4E99-92CC-257CF8B119BFQ53369810-E04DE02C-646E-4D3D-869D-53CFDBD7CBA1Q54607197-DC60B0E0-1C32-4A8F-BE1B-ED0B72BCD882Q54963873-3D4E7589-D0D1-4395-836A-A565DB110D7CQ55004192-116C232D-FF65-4997-A131-CBA37361FA4EQ55117305-85BA71EB-89CB-4954-8FBA-2C71C99B5003Q57177421-6170BF9D-BF73-40F2-A26D-950767D5D54CQ58732188-41570AB5-7BE0-44D3-A3C9-7FF9D06AF8B1
P2860
Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Plasma Septin9 versus fecal im ...... prospective multicenter study
@ast
Plasma Septin9 versus fecal im ...... prospective multicenter study
@en
type
label
Plasma Septin9 versus fecal im ...... prospective multicenter study
@ast
Plasma Septin9 versus fecal im ...... prospective multicenter study
@en
prefLabel
Plasma Septin9 versus fecal im ...... prospective multicenter study
@ast
Plasma Septin9 versus fecal im ...... prospective multicenter study
@en
P2093
P2860
P921
P1433
P1476
Plasma Septin9 versus fecal im ...... prospective multicenter study
@en
P2093
David A Johnson
Gunter Weiss
Jürgen Beck
Klaus Mergener
Nicholas T Potter
Robert L Barclay
Thomas König
P2860
P304
P356
10.1371/JOURNAL.PONE.0098238
P407
P577
2014-06-05T00:00:00Z